Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page
- Check2 days agoChange DetectedThe site footer’s revision label changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check16 days agoChange DetectedThe study page displays a 403 Forbidden message with a Home link in place of study content.SummaryDifference0.5%

- Check30 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the study details, indicating an access restriction or server issue. This changes the visible content from trial information to an error page for the NCT03053050 study.SummaryDifference16%

- Check51 days agoChange DetectedThe page revision updates from v3.6.5 to v3.6.6, indicating a small backend/content adjustment rather than a substantive change to study details or features.SummaryDifference0.0%

- Check58 days agoChange DetectedA new entry, '2016 ( U.S. NIH Grant/Contract )', was added to the list of study identifiers in the 'Other Study ID Numbers' section, indicating NIH funding for the trial.SummaryDifference0.0%

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.